News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,616 Results
Type
Article (89010)
Company Profile (555)
Press Release (797033)
Multimedia
Podcasts (250)
Webinars (37)
Section
Business (267108)
Career Advice (4167)
Deals (40040)
Drug Delivery (182)
Drug Development (91811)
Employer Resources (208)
FDA (18618)
Job Trends (17503)
News (398967)
Policy (40028)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3069)
Academic (2)
Accelerated approval (60)
ADA (50)
Adcomms (43)
Allergies (213)
Alliances (56991)
ALS (246)
Alzheimer's disease (2052)
Antibody-drug conjugate (ADC) (604)
Approvals (19032)
Artificial intelligence (943)
ASCO (345)
Autoimmune disease (392)
Automation (71)
Bankruptcy (409)
Best Places to Work (12635)
BIO (80)
BIOSECURE Act (23)
Biosimilars (266)
Biotechnology (336)
Bladder cancer (220)
Brain cancer (87)
Breast cancer (874)
Cancer (6913)
Cardiovascular disease (584)
Career advice (3604)
Career pathing (55)
CAR-T (401)
CDC (77)
Celiac Disease (3)
Cell therapy (1122)
Cervical cancer (60)
Clinical research (79539)
Collaboration (2516)
Commercialization (4)
Company closure (8)
Compensation (1621)
Complete response letters (118)
COVID-19 (3047)
CRISPR (130)
C-suite (1402)
Cystic fibrosis (170)
Data (9151)
Decentralized trials (3)
Denatured (96)
Depression (208)
Dermatology (112)
Diabetes (740)
Diagnostics (7696)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (479)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (338)
Earnings (102748)
Editorial (81)
Employer branding (25)
Employer resources (178)
Events (139153)
Executive appointments (1249)
FDA (22967)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (23)
Frontotemporal dementia (37)
Funding (2053)
Gene editing (285)
Generative AI (95)
Gene therapy (883)
GLP-1 (1306)
Government (5574)
Grass and pollen (8)
Guidances (429)
Healthcare (21283)
Hematology (198)
HIV (107)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (122)
Immunology and inflammation (372)
Immuno-oncology (124)
Indications (231)
Infectious disease (3463)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (343)
Interviews (823)
IPO (18023)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (27)
Labor market (130)
Layoffs (699)
Leadership (56)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (915)
Lymphoma (498)
Machine learning (70)
Management (69)
Manufacturing (1330)
Marketing (10)
MASH (233)
Medical affairs (1)
Medical device (15334)
Medtech (15547)
Mergers & acquisitions (23402)
Metabolic disorders (1904)
mRNA (283)
Multiple sclerosis (217)
NASH (24)
Neurodegenerative disease (553)
Neuropsychiatric disorders (133)
Neuroscience (3907)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5150)
Now hiring (85)
Obesity (902)
Opinion (385)
Ovarian cancer (257)
Pain (300)
Pancreatic cancer (379)
Parkinson's disease (434)
Partnered (43)
Patents (704)
Patient recruitment (856)
Peanut (72)
People (68290)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24567)
Phase 2 (34544)
Phase 3 (25983)
Pipeline (10701)
Policy (409)
Postmarket research (3561)
Preclinical (11018)
Press Release (72)
Prostate cancer (367)
Psychedelics (82)
Radiopharmaceuticals (388)
Rare diseases (1365)
Real estate (7467)
Recruiting (83)
Regulatory (30821)
Reports (78)
Research institute (2782)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (200)
Series A (351)
Series B (254)
Service/supplier (15)
Sickle cell disease (135)
Special edition (33)
Spinal muscular atrophy (193)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (154)
Tariffs (104)
The Weekly (151)
Vaccines (1343)
Venture capital (144)
Weight loss (611)
Women's health (150)
Worklife (25)
Date
Today (107)
Last 7 days (503)
Last 30 days (2160)
Last 365 days (33405)
2026 (19243)
2025 (33213)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1299)
Alabama (106)
Alaska (7)
Arizona (419)
Arkansas (16)
Asia (52522)
Australia (9234)
California (14914)
Canada (4177)
China (1693)
Colorado (641)
Connecticut (657)
Delaware (462)
Europe (121118)
Florida (2248)
Georgia (485)
Hawaii (4)
Idaho (70)
Illinois (1308)
India (114)
Indiana (688)
Iowa (25)
Japan (639)
Kansas (146)
Kentucky (58)
Louisiana (64)
Maine (92)
Maryland (1790)
Massachusetts (10891)
Michigan (430)
Minnesota (832)
Mississippi (7)
Missouri (170)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3944)
New Mexico (36)
New York (3938)
North Carolina (1972)
North Dakota (11)
Northern California (7465)
Ohio (469)
Oklahoma (29)
Oregon (46)
Pennsylvania (2913)
Puerto Rico (33)
Rhode Island (54)
South America (1671)
South Carolina (92)
South Dakota (2)
Southern California (5889)
Tennessee (243)
Texas (2424)
United States (53237)
Utah (449)
Vermont (2)
Virginia (375)
Washington D.C. (88)
Washington State (1209)
West Virginia (4)
Wisconsin (166)
Wyoming (2)
There are 886,616 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AbBaltis answers customer demand with new Blood Component Processing department
July 24, 2026
·
1 min read
Press Releases
Optimind Pharma Announces Adoption of Semi-Annual Reporting
July 24, 2026
·
4 min read
Drug Development
Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrapped
Sanofi had hoped the acquisition of Kymab would fill a major hole that will be left as autoimmune juggernaut Dupixent heads toward a patent cliff. Now, another therapy has failed to meet expectations.
July 24, 2026
·
3 min read
·
Gabrielle Masson
IPO
Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech
Jennifer Doudna–founded Scribe Therapeutics intends to use the proceeds from the public offering—the first for a gene editing outfit in over two years—to support development of its epigenetic silencing therapy for atherosclerotic cardiovascular disease.
July 24, 2026
·
3 min read
·
Tristan Manalac
Regulatory
Amgen deploys patients to defend troubled Tavneos in FDA hearing request
Facing pressure around the world to withdraw the rare kidney disease drug Tavneos, Amgen has launched a robust defense with real-world evidence to support the product’s benefit-risk profile.
July 24, 2026
·
4 min read
·
Annalee Armstrong
Press Releases
Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma
July 24, 2026
·
4 min read
Press Releases
New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1
July 24, 2026
·
7 min read
Press Releases
Enhertu® Plus Pertuzumab Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer
July 24, 2026
·
13 min read
Press Releases
Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2026
July 24, 2026
·
17 min read
Press Releases
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
July 24, 2026
·
11 min read
1 of 88,662
Next
